
AI Breakthroughs in Medicine, Google's Gemini 2.5 Pro, and Tech Landscape Shifts
In this episode, the focus is on significant shifts in the AI landscape. The episode begins with a look at the stock market turmoil and DeepSeek's AI breakthrough, setting the stage for a discussion on the global tech landscape transformation. Michelle highlights Google's strategy of democratizing AI by making its Gemini 2.5 Pro model free, examining its implications. The conversation extends to Zhipu AI's introduction of a free agent and its performance benchmarks. In the realm of healthcare, the episode explores Weill Cornell's use of AI in precision medicine, specifically in cancer treatment models. The episode concludes with insights into AI's role in personalized cancer treatment and future visions for the field.
Key Points
- DeepSeek's groundbreaking AI technology has caused a major disruption in Silicon Valley, leading to a $1 trillion loss in the U.S. stock market.
- Google's latest AI model, Gemini 2.5 Pro, is now accessible to non-paying users, offering advanced reasoning capabilities but with usage limitations for free accounts.
- Researchers at Weill Cornell Medicine have developed an AI model that integrates tumor imaging and gene expression data, significantly advancing personalized treatment for muscle-invasive bladder cancer.
Chapters
0:00 | |
1:21 | |
2:05 | |
3:33 | |
3:53 | |
6:15 | |
8:14 |
Transcript
Loading transcript...
- / -